STD/STI

This report summarizes results of a study by the Centers for Disease Control and Prevention and the San Francisco Department of Public Health to gather data on rectal and pharyngeal gonorrhea and chlamydia testing at screening sites managed by six gay-focused community-based organizations (CBOs) in five US cities during 2007. The purpose of the study was to determine sexually transmitted disease testing practices among CBOs serving men who have sex with men (MSM). Findings indicate that three organizations collected samples for nucleic acid amplification (NAA) testing and three for culture.

This report on the Gonococcal Isolate Surveillance Project (GISP), a national sentinel surveillance system that monitors trends in antimicrobial susceptibilities of strains of gonorrhea in the United States among selected sexually transmitted diseases clinics in about 25-30 sentinel sites. This report shows site-specific profiles of figures depicting the demographic and clinical data of the patients with gonorrhea enrolled in GISP and the antimicrobial susceptibility results of the gonorrhea isolates submitted.

This report presents statistics and trends for sexually transmitted diseases (STDs) in the United States through 2008. The information is based on (1) notifiable disease reporting from state and local STD programs; (2) projects that monitor STD prevalence in various settings, including the Regional Infertility Prevention Projects (IPP), the National Job Training Program, the Indian Health Service, the Men Who Have Sex with Men (MSM) Prevalence Monitoring Project, and the Gonococcal Isolate Surveillance Project (GISP); and (3) national surveys by federal and private organizations.

This serial updates the 2006 clinical guidelines for treating sexually transmitted diseases (STDs). These recommendations were developed by the Centers for Disease Control and Prevention (CDC) in consultation with professionals knowledgeable about the treatment of STDs.

This report presents data on the impact of chlamydia, gonorrhea, syphilis, and genital herpes on 10-19 year olds in Arizona for 2009. The data were derived from the Arizona Department of Health Services STD Surveillance Database. The data are presented by race/ethnicity, county, and gender for each disease. It includes certain populations such as young adults in juvenile detention facilities. It is noted that chlamydia, gonorrhea, and herpes are more frequently diagnosed in young females than in young males.

This report summarizes the results of a CDC analysis of recent trends in congenital syphilis (CS) rates, using national surveillance data from the years 2003-2008. Results show that after declining for 14 years, the CS rate among infants aged <1 year increased 23 percent, from 8.2 cases per 100,000 live births in 2005 to 10.1 during 2008. The increase followed a 38 percent increase in primary and secondary syphilis rate among females aged =10 years from 2004-2007.

The Centers for Disease Control and Prevention (CDC) analyzed serologic test results from persons aged 14-49 years who participated in the National Health and Nutrition Examination Survey (NHANES) 2005-2008, to determine whether HSV-2 seroprevalence in the United States has changed since 1999-2004. CDC also used the data to estimate HSV-2 seroprevalence by age, race/ethnicity, and reported lifetime number of sex partners. Results indicated that HSV-2 seroprevalence was 16.2 percent overall, not statistically different from that of 1999-2004, and was highest among women and non-Hispanic blacks.

This report summarizes an enhanced outbreak response, which identified 106 cases of syphilis with onset from January 2007 to June 2009, including six congenital cases in a Southwest Indian Nation. The enhanced, coordinated multiagency response involved tribal and Pima County Health Departments, the Indian Health Service (IHS), the Arizona Department of Health Services, and the Centers for Disease Control and Prevention (CDC).

This report present statistics and trends for sexually transmitted diseases (STDs) in the United States through 2009. The information is based on (1) data from notifiable disease reporting from state and local STD programs; (2) projects that monitor STD prevalence in various settings, including Regional Infertility Prevention projects, the National Job Training Program, the Indian Health Service, the STD Surveillance Network, and the Gonococcal Isolate Surveillance Project; and (3) National surveys implemented by federal and private organizations.